Evolus, Inc.
(NASDAQ : EOLS)

( )
EOLS PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
0.04%145.440.6%$1129.68m
PFEPfizer Inc.
-0.29%43.800.9%$994.23m
MRKMerck & Co., Inc.
-1.21%75.780.6%$994.21m
ABBVAbbVie, Inc.
-3.75%86.942.2%$612.33m
LLYEli Lilly and Company
-0.51%113.001.0%$519.97m
BMYBristol-Myers Squibb Company
-0.32%53.081.4%$462.56m
NVSNovartis AG Sponsored ADR
0.28%87.300.2%$236.24m
AZNAstraZeneca PLC Sponsored ADR
2.49%39.131.3%$206.58m
GSKGlaxoSmithKline plc Sponsored ADR
1.10%37.690.2%$137.42m
NVONovo Nordisk A/S Sponsored ADR Class B
1.06%45.860.1%$63.34m
SNYSanofi Sponsored ADR
1.38%44.070.2%$43.09m
LCILannett Company, Inc.
-1.65%5.3737.0%$12.19m

Company Profile

Evolus, Inc. is a medical aesthetics company. The company is engaged in providing physicians and patients with expanded choices in aesthetic procedures and treatments. Evolus was founded in November, 2012 and is headquartered in Irvine, CA.